18/12/2014 02:17:02 Free Membership Login

   

AMAG Pharmaceuticals, Inc.

Visual Financials
Company Name: AMAG Pharmaceuticals, Inc.
Ticker Symbol: AMAG
WWW Address: http://www.amagpharma.com
CEO: William Heiden
No. of Employees: 129
Common Issue Type: CS
Business Description:AMAG Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 40.485 Up 0.195 27.4 40.49 40.48 40.84 39.76 326331
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 894.5 22.1 0.00 -0.44 0.00 0.0 0.0 42.72 - 16.48
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close40.49$
PE Ratio - LTM0.0
Market Capitalisation894.5mil
Latest Shares Outstanding22.1mil
Earnings pS (EPS)-0.44$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float15.5mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.70%
Research & Devlopment (R&D) as % of Revenue0.30%
Gross Profit Margin85.2%
EBITDA Margin-10.6%
Pre-Tax Profit Margin0.0%
Assets Turnover30.9%
Return on Assets (ROA)-3.7%
Return on Equity (ROE)-5.6%
Return on Capital Invested (ROCI)-5.6%
Current Ratio7.4
Leverage Ratio (Assets/Equity)1.5
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS9.56$
Cash pS0.00$
Book-Value pS8.92$
Tangible Book-Value pS7.04$
Cash Flow pS-0.38$
Free Cash Flow pS-0.40$
KEY FIGURES (LTM): Price info
Price/Book Ratio4.49
Price/Tangible Book Ratio0.00
Price/Cash Flow-106.4
Price/Free Cash Flow-99.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---42.7220.5769-0
4 Weeks40.8439.7639.7642.7220.574076
13 Weeks40.4940.4932633133.9542.724176
26 Weeks32633142.7242.7234.7642.724116
52 Weeks34.6834.6835.1642.7216.483516
YTD16.4816.48-42.7216.4873
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
22.4722.4722.9422.9442.720.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue987627261641676164167
Income9876272987627235116370
Dividend351163705476295254762952
Capital Spending109526686NA109526686
R&D7523457NA7523457
Normalized Inc.35116370NA35116370
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %1048888
Earnings %616159
EPS %938787
EPS $59122122
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio265459000
Quick Ratio (Acid Test)21054000
Liquidity Ratio (Cash)0.00
Receivables Turnover8226000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS172408000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)2629000
Debt Ratio93051000
Total Debt/Equity (Gearing Ratio)FI
LT Debt/Equity15396000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities93051000
Interest Cover-496000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM55,110,315.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-111.35
Dividend Yield1489572
Price/Tangible Book Ratio - LTM42
Price/Book Ratio - LTM433559
Price/Cash Flow Ratio7.4
Price/Free Cash Flow Ratio - LTM42
Price/Sales Ratio8.00
P/E Ratio (1 month ago) - LTM55110315
P/E Ratio (26 weeks ago) - LTM82745349
P/E Ratio (52 weeks ago) - LTM82745349
5-Y High P/E Ratio109690490
5-Y Low P/E Ratio108125329
5-Y Average P/E Ratio526790
Current P/E Ratio as % of 5-Y Average P/E526790
P/E as % of Industry Group493,813.0
P/E as % of Sector Segment493,813.0
Current 12 Month Normalized P/E Ratio - LTM560,378.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM7.4
Book Value pS - LTM433559
Capital Invested pS0.00
Cash pS - LTM7598
Cash Flow pS - LTM1.71
Free Cash Flow pS - LTM1.71
Earnings pS (EPS)-30
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-496000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)172408000
Return on Equity (ROE) - 5YEAR AVRG.884674550
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-91
Assets Productivity2,629,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.884674550
Gross Profit Margin493813
Gross Profit Margin - 5YEAR AVRG.-91
EBITDA Margin - LTM540251
EBIT Margin - LTM493813
Pre-Tax Profit Margin1846000
Pre-Tax Profit Margin - 5YEAR AVRG.22094769
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle33,121,818
Revenue per Employee
Net Income per Employee16,844,000
Average Collection Period
Receivables Turnover8226000
Day's Inventory Turnover Ratio33121000
Inventory Turnover8226000
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover2629000
Revenue per $ Cash22266000
Revenue per $ Plant22266000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.22094769
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq amag141218 02:17